Analytical Data
-
Gene name
Q677H
- Application
-
Alternative Names
(S glycoprotein)(E2)(Peplomer protein)
-
Species
SARS-CoV-2
-
Source
HEK293
-
Tag
C- mFc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0DTC2
-
Expression Region
16-685aa(Q677H)
-
Molecular Weight
104.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Q677H is a variant of a specific protein that has garnered attention in the field of molecular biology and genetics due to its potential implications in disease mechanisms and therapy development. The research surrounding this recombinant protein focuses on understanding how the Q677H mutation affects the protein's structure, function, and interaction with other biomolecules. Studies have shown that mutations like Q677H can alter enzymatic activity, stability, or binding affinities, which may lead to significant physiological consequences. This variant is particularly relevant in contexts such as cancer research, metabolic disorders, and gene therapy, highlighting the need for a comprehensive understanding of its biological role. Furthermore, the use of recombinant technology allows for the production of the Q677H variant in controlled laboratory settings, facilitating detailed characterization studies, functional assays, and potential therapeutic applications. Investigating this protein variant not only contributes to the broader understanding of protein dynamics and disease-related mutations but also opens avenues for the development of targeted treatments that can mitigate the negative effects of such mutations in affected individuals.
